Valuation : Nephros, Inc.

Market Cap 47.35M 40.71M 38.3M 34.95M 65.23M 4.49B 65.57M 454M 176M 2.29B 178M 174M 7.3B P/E 2026 *
27.8x
P/E 2027 * 16.8x
Enterprise Value 47.35M 40.71M 38.3M 34.95M 65.23M 4.49B 65.57M 454M 176M 2.29B 178M 174M 7.3B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 1.85x
Free-Float
87.11%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 51 04/05/2023
Director of Finance/CFO 60 31/10/2023
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 69 18/09/2007
Director/Board Member 54 09/08/2018
Director/Board Member 58 07/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-1.69% - - 47.35M
+0.93%+1.51% - - 13.12B
-0.04%+1.37%+12.00%+47.14% 10.55B
+6.79%+12.16%+75.38%+475.91% 4.63B
+1.09%+0.48%+6.54%+225.55% 3.7B
-1.31%+19.72% - - 1.35B
-0.77%-1.96%+25.29%+74.62% 1.3B
-6.98%+1.56%+143.28%+142.63% 947M
+3.66%+3.35%+217.83%+256.39% 966M
+2.32%-0.71%+133.85%+158.88% 875M
Average +0.57%+1.17%+87.74%+197.30% 4.16B
Weighted average by Cap. +1.16%+0.87%+43.37%+180.96%

Financials

2026 *2027 *
Net sales 22.14M 19.03M 17.91M 16.34M 30.49M 2.1B 30.65M 212M 82.08M 1.07B 83.12M 81.31M 3.41B 25.66M 22.06M 20.75M 18.94M 35.34M 2.43B 35.53M 246M 95.13M 1.24B 96.34M 94.24M 3.96B
Net income 1.76M 1.52M 1.43M 1.3M 2.43M 167M 2.44M 16.91M 6.54M 85.49M 6.63M 6.48M 272M 2.92M 2.51M 2.36M 2.15M 4.02M 276M 4.04M 27.95M 10.81M 141M 10.95M 10.71M 450M
Net Debt - -
Logo Nephros, Inc.
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!